[Our experience in the treatment of the parkinsonian syndrome with L-dopa. I. Evaluation of the clinical results].
D004295:Dihydroxyphenylalanine / Q000627:therapeutic use*; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000150:complications; D010300:Parkinson Disease / Q000188:drug therapy*; D010301:Parkinson Disease, Postencephalitic / Q000188:drug therapy*
D004295:Dihydroxyphenylalanine
Nostra esperienza sul trattamento della sindrome parkinsoniana con L-Dopa. I. Valutazione dei risultati clinici.